News Releases Year None2023202220212020201920182017 NuCana Announces Presentations at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023 Sep 18, 2023 NuCana Reports Second Quarter 2023 Financial Results and Provides Business Update Aug 16, 2023 NuCana to Present at the Jefferies Healthcare Conference Jun 01, 2023 NuCana Reports First Quarter 2023 Financial Results and Provides Business Update May 17, 2023 NuCana Announces Receipt of Nasdaq Notice May 12, 2023 NuCana Presents Data at the AACR 2023 Annual Meeting Highlighting Novel NUC-7738 Mechanisms of Action Apr 14, 2023 NuCana Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Business Update Apr 04, 2023 Technical Board of Appeal of the European Patent Office Issues Oral Ruling that NuCana’s ‘190 Patent is Not Valid Mar 24, 2023 NuCana to Participate in Two Upcoming Investor Conferences Feb 28, 2023 NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement Jan 23, 2023 Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »
NuCana Announces Presentations at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023 Sep 18, 2023
NuCana Presents Data at the AACR 2023 Annual Meeting Highlighting Novel NUC-7738 Mechanisms of Action Apr 14, 2023
NuCana Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Business Update Apr 04, 2023
Technical Board of Appeal of the European Patent Office Issues Oral Ruling that NuCana’s ‘190 Patent is Not Valid Mar 24, 2023